Cargando…
Nirmatrelvir–remdesivir association for non-hospitalized adults with COVID-19, point of view
The efforts of the scientific world directed to identifying new antiviral drugs and therapies effective against SARS-CoV-2 continue. New oral antivirals against SARS-CoV-2 such as paxlovid have recently authorized. Evidence shows that these antivirals have good efficacy in reducing the risk of hospi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386652/ https://www.ncbi.nlm.nih.gov/pubmed/35980509 http://dx.doi.org/10.1007/s10787-022-01055-2 |